Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary SyndromesChristopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
European Journal of Heart Failure|June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESCGabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
Journal of the American College of Cardiology|November 30, 2019
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE TrialDavid A Wood, John A Cairns, Jia Wang, et al.
European Journal of Heart Failure|March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESCDavide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
American Heart Journal|August 30, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and designSneha S Jain, Kenneth W Mahaffey, Karen S Pieper, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
European Journal of Heart Failure|May 27, 2019
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of CardiologyPetar M Seferovic, Piotr Ponikowski, Stefan D Anker, et al.
The New England Journal of Medicine|April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular DiseaseSalim Yusuf, Eva Lonn, Prem Pais, et al.
The New England Journal of Medicine|April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular DiseaseSalim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
European Heart Journal|September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trialC Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
Pageof 22